ABT Abbott Laboratories

By Will Feuer

The U.S. Food and Drug Administration said it has secured an additional roughly 1.4 million pounds of baby formula that is expected to be available early next month.

Government officials and formula manufacturers are working to address a nationwide shortage that in recent months has resulted in empty shelves at some stores. Causes for the shortage include pandemic-related supply-chain snarls, a February recall by Abbott Laboratories, as well as the closing of one of its factories.

The agency said it has secured two products, Bellamy's Organic Infant Formula Step 1, which is for new-born children up to six months old, and Bellamy's Organic Follow-On Formula Step 2, which is for those between six months and 12 months old.

The agency said that the U.S. Department of Health and Human Services is evaluating options for getting the product to the U.S. as quickly as possible.

Write to Will Feuer at Will.Feuer@wsj.com

(END) Dow Jones Newswires

June 27, 2022 09:52 ET (13:52 GMT)

Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024

Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024